UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Peptide Degrader-Based Targeting of METTL3/14 Improves Immunotherapy Response in Cutaneous Melanoma Journal article
Han, Hong, Li, Zenghui, Feng, Yuqing, Song, He, Fang, Zhixiong, Zhang, Dingxiao, Yuan, Dan, Shi, Junfeng. Peptide Degrader-Based Targeting of METTL3/14 Improves Immunotherapy Response in Cutaneous Melanoma[J]. Angewandte Chemie-International Edition, 2024, 63(48), e202407381.
Authors:  Han, Hong;  Li, Zenghui;  Feng, Yuqing;  Song, He;  Fang, Zhixiong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:16.1/16.2 | Submit date:2024/11/05
Degradation  Immunotherapy  Melanoma  Mettl3  Peptide